A retrospective study comparing Effect of initial high-efficacy disease modifying therapy similar patients started on moderately effective disease modifying therapies (meDMT)
Latest Information Update: 23 Jan 2020
At a glance
- Drugs Alemtuzumab (Primary) ; Fingolimod (Primary) ; Natalizumab (Primary) ; Ofatumumab (Primary) ; Rituximab (Primary) ; Dimethyl fumarate; Glatiramer acetate; Interferon beta; Teriflunomide
- Indications Multiple sclerosis
- Focus Therapeutic Use
Most Recent Events
- 23 Jan 2020 New trial record